If you have any questions about pricing or financing options, please feel free to give our office a call at 303-839-7980 or fill out our contact form
All strengths will be available from the manufacturer as the shortage has ended, but after April 22, 2025, compounding pharmacies will be only able to make custom doses
Switching patterns following formulary change Switching from AOM tirzepatide remained rare prior to May 2025, averaging 0.6% of patients who switched to a different GLP-1 in the following month
Preventing Deficiencies Given semaglutides influence on gastric emptying, supplementation with B6 and B12 ensures the body maintains adequate nutrient levels, minimizing health risks and supporting the medications effectiveness
Access to healthcare professionals: These services work with board certified healthcare professionals to review responses, provide consultations, and prescribe medication
Since semaglutide injections are not taken orally, they do not directly compete with levothyroxine absorption, but the delayed gastric motility from GLP-1 use means your provider may want to recheck thyroid labs after dose adjustments to ensure adequate hormone absorption